Insider · CIK 0001651325

Kosaraju Sridhar

Reports to the SEC for 3 companies · PLEASANTON, CA

sec.gov

Transactions

Companies

Filings

CIK

0001651325

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	TXG10x Genomics, Inc.A Award	Director	AAward	+8,829 sh	—	—	65,278
2025-06-03	TXG10x Genomics, Inc.A Award	Director	AAward	+15.4K sh	—	—	56,449
2025-04-03	NEVRO CORPD Disposition to Issuer	Director	DDisposition to Issuer	−46.6K sh	—	—	0
2024-12-31	NEVRO CORPA Award	Director	AAward	+4,233 sh	—	—	46,575
2024-09-30	NEVRO CORPA Award	Director	AAward	+2,817 sh	—	—	42,342
2024-06-30	NEVRO CORPA Award	Director	AAward	+1,870 sh	—	—	39,525
2024-06-11	TXG10x Genomics, Inc.A Award	Director	AAward	+8,649 sh	—	—	41,092
2024-05-23	NEVRO CORPA Award	Director	AAward	+19.2K sh	—	—	37,655
2024-03-31	NEVRO CORPA Award	Director	AAward	+1,090 sh	—	—	18,486
2023-12-31	NEVRO CORPA Award	Director	AAward	+731 sh	—	—	17,396
2023-09-30	NEVRO CORPA Award	Director	AAward	+819 sh	—	—	16,665
2023-06-30	NEVRO CORPA Award	Director	AAward	+619 sh	—	—	15,846
2023-06-14	TXG10x Genomics, Inc.A Award	Director	AAward	+1,865 sh	—	—	32,443
2023-06-14	TXG10x Genomics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,661 sh	—	—	4,661
2023-05-25	NEVRO CORPA Award	Director	AAward	+6,754 sh	—	—	15,227
2023-03-31	NEVRO CORPA Award	Director	AAward	+435 sh	—	—	8,473
2022-12-30	NEVRO CORPA Award	Director	AAward	+397 sh	—	—	8,038
2022-09-30	NEVRO CORPA Award	Director	AAward	+337 sh	—	—	7,641
2022-09-14	TXG10x Genomics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$11.48	+$115K	30,578
2022-09-14	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	84,167
2022-06-30	NEVRO CORPA Award	Director	AAward	+331 sh	—	—	7,304
2022-06-15	TXG10x Genomics, Inc.A Award	Director	AAward	+2,120 sh	—	—	20,578
2022-06-15	TXG10x Genomics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2022-05-26	NEVRO CORPA Award	Director	AAward	+4,155 sh	—	—	6,973
2022-05-16	TXG10x Genomics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$11.48	+$172K	18,458
2022-05-16	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	94,167
2022-03-31	NEVRO CORPA Award	Director	AAward	+190 sh	—	—	2,818
2021-12-31	NEVRO CORPA Award	Director	AAward	+169 sh	—	—	2,628
2021-12-30	TXG10x Genomics, Inc.S Sale	Director	SSale	−1,500 sh	$150.38	−$226K	3,000
2021-11-24	TXG10x Genomics, Inc.S Sale	Director	SSale	−1,500 sh	$150.06	−$225K	4,500
2021-10-25	TXG10x Genomics, Inc.S Sale	Director	SSale	−100 sh	$163.85	−$16.4K	7,400
2021-10-25	TXG10x Genomics, Inc.S Sale	Director	SSale	−600 sh	$165.14	−$99.1K	6,800
2021-10-25	TXG10x Genomics, Inc.S Sale	Director	SSale	−400 sh	$166.60	−$66.6K	6,400
2021-10-25	TXG10x Genomics, Inc.S Sale	Director	SSale	−100 sh	$167.63	−$16.8K	6,300
2021-10-25	TXG10x Genomics, Inc.S Sale	Director	SSale	−300 sh	$168.68	−$50.6K	6,000
2021-09-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−400 sh	$157.71	−$63.1K	8,600
2021-09-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−1,100 sh	$159.52	−$175K	7,500
2021-08-31	NEVRO CORPA Award	Director	AAward	+2,459 sh	—	—	2,459
2021-08-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−200 sh	$157.72	−$31.5K	10,300
2021-08-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−100 sh	$160.56	−$16.1K	10,200
2021-08-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−500 sh	$162.27	−$81.1K	9,700
2021-08-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−600 sh	$163.25	−$97.9K	9,100
2021-08-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−100 sh	$164.05	−$16.4K	9,000
2021-07-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−459 sh	$182.32	−$83.7K	11,541
2021-07-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−400 sh	$183.07	−$73.2K	11,141
2021-07-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−400 sh	$184.43	−$73.8K	10,741
2021-07-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−241 sh	$185.96	−$44.8K	10,500
2021-06-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−200 sh	$197.26	−$39.5K	13,300
2021-06-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−400 sh	$199.40	−$79.8K	12,900
2021-06-23	TXG10x Genomics, Inc.S Sale	Director	SSale	−500 sh	$200.03	−$100K	12,400

Recent filings

Accepted (ET)
Jun 84
Kosaraju Sridhar0001610717-26-000191
SEC(opens sec.gov)
Jun 54
Kosaraju Sridhar0001610717-25-000167
SEC(opens sec.gov)
Apr 34
Kosaraju Sridhar0000950170-25-050475
SEC(opens sec.gov)
Jan 24
Kosaraju Sridhar0001444380-25-000004
SEC(opens sec.gov)
Oct 24
Kosaraju Sridhar0001610717-24-000499
SEC(opens sec.gov)
Jul 24
Kosaraju Sridhar0001610717-24-000382
SEC(opens sec.gov)
Jun 134
Kosaraju Sridhar0001610717-24-000329
SEC(opens sec.gov)
May 284
Kosaraju Sridhar0001610717-24-000266
SEC(opens sec.gov)
Apr 24
Kosaraju Sridhar0001610717-24-000203
SEC(opens sec.gov)
Jan 34
Kosaraju Sridhar0001610717-24-000005
SEC(opens sec.gov)
Oct 34
Kosaraju Sridhar0001610717-23-000305
SEC(opens sec.gov)
Jul 54
Kosaraju Sridhar0001610717-23-000198
SEC(opens sec.gov)
Jun 164
Kosaraju Sridhar0001610717-23-000172
SEC(opens sec.gov)
May 304
Kosaraju Sridhar0001610717-23-000076
SEC(opens sec.gov)
Apr 44
Kosaraju Sridhar0001140361-23-016269
SEC(opens sec.gov)
Jan 44
Kosaraju Sridhar0001567619-23-000253
SEC(opens sec.gov)
Oct 44
Kosaraju Sridhar0001567619-22-018222
SEC(opens sec.gov)
Sep 164
Kosaraju Sridhar0001567619-22-017560
SEC(opens sec.gov)

Companies

Address

C/O 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD

PLEASANTON, CA, 94588